Cargando…
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells’ vulnerability to DNA-damaging agents
Genomic instability plays a pathological role in various malignancies, including acute myeloid leukemia (AML), and thus represents a potential therapeutic target. Recent studies demonstrate that SIRT6, a NAD(+)-dependent nuclear deacetylase, functions as genome-guardian by preserving DNA integrity i...
Autores principales: | Cagnetta, Antonia, Soncini, Debora, Orecchioni, Stefania, Talarico, Giovanna, Minetto, Paola, Guolo, Fabio, Retali, Veronica, Colombo, Nicoletta, Carminati, Enrico, Clavio, Marino, Miglino, Maurizio, Bergamaschi, Micaela, Nahimana, Aimable, Duchosal, Michel, Todoerti, Katia, Neri, Antonino, Passalacqua, Mario, Bruzzone, Santina, Nencioni, Alessio, Bertolini, Francesco, Gobbi, Marco, Lemoli, Roberto M., Cea, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777193/ https://www.ncbi.nlm.nih.gov/pubmed/29025907 http://dx.doi.org/10.3324/haematol.2017.176248 |
Ejemplares similares
-
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs
por: Soncini, Debora, et al.
Publicado: (2019) -
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma
por: Gelli, Elisa, et al.
Publicado: (2023) -
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD(+)-Lowering Agents
por: Becherini, Pamela, et al.
Publicado: (2023) -
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment
por: Soncini, Debora, et al.
Publicado: (2021) -
Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery
por: Ghanem, Moustafa S., et al.
Publicado: (2022)